Brief: Apontis Pharma Appoints Thomas Zimmermann As New CFO
Dec 16 (Reuters) - APONTIS PHARMA AG APPHG.DE :
* STRENGTHENS MANAGEMENT FOR FUTURE GROWTH: THOMAS
ZIMMERMANN
APPOINTED NEW CFO
* MR. ZIMMERMANN WILL JOIN MANAGEMENT TEAM LED BY CHIEF
EXECUTIVE
OFFICER (CEO) KARLHEINZ GAST AND CHIEF PRODUCT OFFICER (CPO)
THOMAS MILZ AS OF 1 JANUARY 2022
* AS CFO, THOMAS ZIMMERMANN WILL ASSUME RESPONSIBILITY FOR
FINANCE, SUPPLY CHAIN, AND IT
Source text for Eikon: ID:nEQf4ga
Further company coverage: APPHG.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Apontis Pharma AG
See all newsBrief: Bruno Wohschlegel To Leave Apontis Pharma As CEO End Of August
Brief: APONTIS PHARMA Q1 EBITDA EUR 1.3 Million
Brief: Apontis Pharma Says Zentiva AG Submits Formal Request To Carry Out A Merger
Brief: Zentiva Says Amendeds Offer To Acquire Each Outstanding Share Of Apontis Pharma In Cash By Waiving Condition Of A Minimum Acceptance
Brief: Apontis Pharma: Zentiva To Launch Voluntary Public Purchase Offer At EUR 10.00 Per Share